Recently, Canadian, US and European health regulatory agencies issued warnings about an increased risk of stroke and death in elderly patients with dementia receiving atypical antipsychotics. Assessing both randomised and non-randomised evidence, this systematic review found conflicting findings, particularly for risperidone. More research is needed to better inform clinical practice. © 2008 Bentham Science Publishers Ltd.

Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review

MAZZUCCO, Sara;CIPRIANI, Andrea;BARBUI, Corrado;MONACO, Salvatore
2008

Abstract

Recently, Canadian, US and European health regulatory agencies issued warnings about an increased risk of stroke and death in elderly patients with dementia receiving atypical antipsychotics. Assessing both randomised and non-randomised evidence, this systematic review found conflicting findings, particularly for risperidone. More research is needed to better inform clinical practice. © 2008 Bentham Science Publishers Ltd.
Atypical antipsychotics; Cerebrovascular events; Dementia; Dopamine; Neuroleptics; Typical antipsychotics;
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/320257
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 13
social impact